Beijing Strong Biotechnologies Inc (300406) — Working Capital to Net Assets Ratio
Beijing Strong Biotechnologies Inc (300406) has a Working Capital to Net Assets ratio of 55.6% as of September 2025. Working capital of CN¥2.22 Billion (current assets of CN¥2.43 Billion minus current liabilities of CN¥208.32 Million) is measured against net assets of CN¥4.00 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See defensive interval ratio of Beijing Strong Biotechnologies Inc to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Beijing Strong Biotechnologies Inc Working Capital to Net Assets (2011–2024)
This chart shows how Beijing Strong Biotechnologies Inc's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 55.6%, reflecting working capital of CN¥2.22 Billion against net assets of CN¥4.00 Billion CNY. For the complete balance sheet picture, see 300406 total asset value.
Annual Working Capital to Net Assets for Beijing Strong Biotechnologies Inc (2011–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Beijing Strong Biotechnologies Inc from 2011 to 2024, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check financial resilience of Beijing Strong Biotechnologies Inc to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 55.7% | CN¥2.30 Billion | CN¥4.13 Billion | CN¥2.58 Billion | CN¥278.13 Million | ▲ +1.0 pp |
| 2023 | 54.7% | CN¥2.04 Billion | CN¥3.72 Billion | CN¥2.33 Billion | CN¥297.12 Million | ▲ +0.6 pp |
| 2022 | 54.1% | CN¥1.77 Billion | CN¥3.27 Billion | CN¥2.07 Billion | CN¥297.94 Million | ▲ +15.2 pp |
| 2021 | 38.9% | CN¥1.13 Billion | CN¥2.91 Billion | CN¥1.74 Billion | CN¥607.60 Million | ▼ -5.8 pp |
| 2020 | 44.7% | CN¥1.53 Billion | CN¥3.42 Billion | CN¥1.77 Billion | CN¥242.62 Million | ▼ -1.2 pp |
| 2019 | 45.9% | CN¥903.94 Million | CN¥1.97 Billion | CN¥1.06 Billion | CN¥155.97 Million | ▼ -19.9 pp |
| 2018 | 65.8% | CN¥1.12 Billion | CN¥1.70 Billion | CN¥1.27 Billion | CN¥152.04 Million | ▼ -6.8 pp |
| 2017 | 72.5% | CN¥1.11 Billion | CN¥1.53 Billion | CN¥1.28 Billion | CN¥172.33 Million | ▼ -15.0 pp |
| 2016 | 87.6% | CN¥1.22 Billion | CN¥1.39 Billion | CN¥1.29 Billion | CN¥77.84 Million | ▼ -2.2 pp |
| 2015 | 89.8% | CN¥1.05 Billion | CN¥1.18 Billion | CN¥1.13 Billion | CN¥79.36 Million | ▼ -3.4 pp |
| 2014 | 93.1% | CN¥919.31 Million | CN¥987.03 Million | CN¥968.43 Million | CN¥49.12 Million | ▲ +10.1 pp |
| 2013 | 83.0% | CN¥395.54 Million | CN¥476.31 Million | CN¥436.77 Million | CN¥41.23 Million | ▲ +3.6 pp |
| 2012 | 79.5% | CN¥306.54 Million | CN¥385.67 Million | CN¥350.01 Million | CN¥43.47 Million | ▲ +3.5 pp |
| 2011 | 76.0% | CN¥219.34 Million | CN¥288.66 Million | CN¥246.95 Million | CN¥27.62 Million | — |